An Open Label, Multi-Center, Long-Term Follow-up Study to Evaluate the Safety of PHX1149T in Subjects With Type 2 Diabetes Mellitus - Extension to Protocol PHX1149-PROT202
An Open Label, Multi-Center, Long-Term Follow-up Study to Evaluate the Safety of PHX1149T in Subjects With Type 2 Diabetes Mellitus - Extension to Protocol PHX1149-PROT202
The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.
Inclusion Criteria:
Exclusion Criteria:
Cuidad Autonoma de Buenos Aires, Buenos Aires, Argentina
Samia, Ontario, Canada
Ellisbridge, Ahmedabad, India
Punjagutta, Hyderabad, India
Monterrey N. L., Nuevo León, Mexico